fingolimod hydrochloride has been researched along with Cerebromeningitis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aktas, O; Bielor, C; Hartung, HP; Kremer, D; MacKenzie, C; Müller, AK; Weyers, V; Wienemann, T | 1 |
| Amiri, MRM; Baghbanian, SM | 1 |
| Alkabie, S; Cuascut, FX; Hutton, GJ | 1 |
| Achtnichts, L; Conen, A; Fux, CA; Nedeltchev, K; Obreja, O | 1 |
4 other study(ies) available for fingolimod hydrochloride and Cerebromeningitis
| Article | Year |
|---|---|
Cryptococcal meningoencephalitis in an IgG
Topics: Cryptococcosis; Female; Fingolimod Hydrochloride; Humans; Immunoglobulin G; Immunosuppressive Agents; Lymphopenia; Meningoencephalitis; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Opportunistic Infections | 2020 |
Cryptococcal meningoencephalitis in a multiple sclerosis patient after fingolimod discontinuation-a case report.
Topics: Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Meningoencephalitis; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting | 2021 |
Fingolimod-related cryptococcal meningoencephalitis and immune reconstitution inflammatory syndrome in a patient with multiple sclerosis.
Topics: Fingolimod Hydrochloride; Humans; Immune Reconstitution Inflammatory Syndrome; Immunosuppressive Agents; Meningitis, Cryptococcal; Meningoencephalitis; Multiple Sclerosis | 2021 |
Cryptococcal Meningoencephalitis in a Patient With Multiple Sclerosis Treated With Fingolimod.
Topics: Adult; Brain; Cryptococcosis; Cryptococcus; Fingolimod Hydrochloride; Humans; Male; Meningoencephalitis; Multiple Sclerosis; Treatment Outcome | 2015 |